43 assets in Acute Leukemia Of Ambiguous Lineage

Therapeutic assets addressing Acute Leukemia Of Ambiguous Lineage, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	BB (64)
Cytarabine Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (62)
Vincristine Sulfate Acute Leukemia Of Ambiguous Lineage	Children's Oncology Group	P2	B (61)
Fludarabine Acute Leukemia Of Ambiguous Lineage	Janssen Research & Development, LLC	P2	B (60)
Methotrexate Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (60)
Dexasone Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (59)
Revumenib Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (59)
(+)-Vincristine Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (59)
Cladribine Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (58)
Idarubicin Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (58)
Pegaspargase Acute Leukemia Of Ambiguous Lineage	Janssen Research & Development, LLC	P2	B (58)
Azacitidine Acute Leukemia Of Ambiguous Lineage	St. Jude Children's Research Hospital	P2	B (57)
Hydrocortisone Acute Leukemia Of Ambiguous Lineage	National Cancer Institute (NCI)	P2	B (57)
Mitoxantrone Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (57)
Nivestim Acute Leukemia Of Ambiguous Lineage	St. Jude Children's Research Hospital	P2	B (57)
Thiotepa Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (57)
Busulfanum Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (56)
Tacrolimus Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (56)
Adriamycin Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	CCC (55)
Calaspargase Pegol Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	CCC (55)
Cyclosporin A Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	CCC (55)
Prednisone Acute Leukemia Of Ambiguous Lineage	National Cancer Institute (NCI)	P2	CCC (55)
Venetoclax Acute Leukemia Of Ambiguous Lineage	National Cancer Institute (NCI)	P2	CCC (55)
Daunomycin Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	CCC (54)
Mercaptopurine Anhydrous Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	CCC (54)
Prednisolone Acute Leukemia Of Ambiguous Lineage	National Cancer Institute (NCI)	P2	CCC (54)
Thioguanine Anhydrous Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	CCC (54)
Melphalan Acute Leukemia Of Ambiguous Lineage	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 Acute Leukemia Of Ambiguous Lineage	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Blinatumomab Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	CCC (51)
Crisantaspase Acute Leukemia Of Ambiguous Lineage	National Cancer Institute (NCI)	P2	CCC (51)
Ebx-102 Acute Leukemia Of Ambiguous Lineage	Imperial College London	P2	CCC (51)
Levofolinic Acid Acute Leukemia Of Ambiguous Lineage	National Cancer Institute (NCI)	P2	CCC (51)
Pbsc Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	CCC (51)
Recombinant Human Granulocyte Colony-Stimulating Factor Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	CCC (51)
18f-flt Acute Leukemia Of Ambiguous Lineage	University of Oklahoma	P1	CC (43)
Cobicistat Acute Leukemia Of Ambiguous Lineage	Syndax Pharmaceuticals	P1/2	CC (43)
Erwinia L-Asparaginase Acute Leukemia Of Ambiguous Lineage	Andrew E. Place, MD	P1	CC (43)
Itraconazole Acute Leukemia Of Ambiguous Lineage	Kura Oncology, Inc.	P1/2	CC (43)
Midazolam Acute Leukemia Of Ambiguous Lineage	Kura Oncology, Inc.	P1/2	CC (43)
Selinexor Acute Leukemia Of Ambiguous Lineage	St. Jude Children's Research Hospital	P1	CC (43)
Ziftomenib Acute Leukemia Of Ambiguous Lineage	Kura Oncology, Inc.	P1/2	CC (43)
Jnj-75276617 Acute Leukemia Of Ambiguous Lineage	Janssen Research & Development, LLC	P1	C (39)